Related references
Note: Only part of the references are listed.In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
Ruth G. M. Keijsers et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical and MRI phenotypes of sarcoidosis-associated myelopathy
Olwen C. Murphy et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Sarcoidosis of the central nervous system: Safety and efficacy of treatment, and experience of biological therapies
Desmond P. Kidd
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Infliximab treatment in pathology-confirmed neurosarcoidosis
Daan Fritz et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis A Single Institution Case Series
Edgar G. Ordonez-Rubiano et al.
SPINE (2019)
Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature
Neetu Soni et al.
NEURORADIOLOGY JOURNAL (2019)
Phenotypes of organ involvement in sarcoidosis
Jonas Christian Schupp et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Definition and Consensus Diagnostic Criteria for Neurosarcoidosis From the Neurosarcoidosis Consortium Consensus Group
Barney J. Stern et al.
JAMA NEUROLOGY (2018)
Long-term outcomes of refractory neurosarcoidosis treated with infliximab
Fleur Cohen Aubart et al.
JOURNAL OF NEUROLOGY (2017)
Infliximab for the treatment of CNS sarcoidosis A multi-institutional series
Jeffrey M. Gelfand et al.
NEUROLOGY (2017)
Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis
Bastien Joubert et al.
JAMA NEUROLOGY (2017)
Discriminating Long Myelitis of Neuromyelitis Optica from Sarcoidosis
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2016)
Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis
Daan Fritz et al.
BMC NEUROLOGY (2016)
Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients
Cecile-Audrey Durel et al.
JOURNAL OF NEUROLOGY (2016)
Neurosarcoidosis in a Tertiary Referral Center A Cross-Sectional Cohort Study
Sonja E. Leonhard et al.
MEDICINE (2016)
Treatment of neurosarcoidosis A comparative study of methotrexate and mycophenolate mofetil
Samuel Bitoun et al.
NEUROLOGY (2016)
Overview of neurosarcoidosis: recent advances
Renata Hebel et al.
JOURNAL OF NEUROLOGY (2015)
Spinal Cord Neurosarcoidosis
Mimi Sohn et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2014)
Therapy for sarcoidosis: evidence-based recommendations
Robert P. Baughman et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis
Ken Sakushima et al.
JOURNAL OF NEUROLOGY (2011)
Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients
Ken Sakushima et al.
JOURNAL OF NEUROLOGY (2011)
Spinal Cord Sarcoidosis Clinical and Laboratory Profile and Outcome of 31 Patients in a Case-Control Study
Fleur Cohen-Aubart et al.
MEDICINE (2010)
Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study
Amanda C. Schutt et al.
RESPIRATORY MEDICINE (2010)
18F-FDG PET successfully detects spinal cord sarcoidosis
Kiyobumi Ota et al.
JOURNAL OF NEUROLOGY (2009)
Medical progress: Sarcoidosis
Michael C. Iannuzzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
Robert P. Baughman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)